Cargando…

Structural neuroimaging differentiates vulnerability from disease manifestation in colombian families with Huntington's disease

INTRODUCTION: The volume of the striatal structures has been associated with disease progression in individuals with Huntington's disease (HD) from North America, Europe, and Australia. However, it is not known whether the gray matter (GM) volume in the striatum is also sensitive in differentia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Valdés Hernández, Maria del C., Abu‐Hussain, Janna, Qiu, Xinyi, Priller, Josef, Parra Rodríguez, Mario, Pino, Mariana, Báez, Sandra, Ibáñez, Agustín
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710228/ https://www.ncbi.nlm.nih.gov/pubmed/31276317 http://dx.doi.org/10.1002/brb3.1343

Ejemplares similares

Motor–Language Coupling in Huntington’s Disease Families
por: Kargieman, Lucila, et al.
Publicado: (2014)

Brain, cognitive, and physical disability correlates of decreased quality of life in patients with Huntington’s disease
por: Junca, Estefanía, et al.
Publicado: (2022)

Ocular Manifestations in Colombian Patients with Systemic Rheumatologic Diseases
por: Uribe-Reina, Pilar, et al.
Publicado: (2021)

Retinal thickness as a biomarker of cognitive impairment in manifest Huntington’s disease
por: Murueta-Goyena, Ane, et al.
Publicado: (2023)

Cortical neurodevelopment in pre-manifest Huntington's disease
por: Kubera, Katharina M., et al.
Publicado: (2019)

Peripheral Biomarkers in Manifest and Premanifest Huntington’s Disease
por: Morena, Emanuele, et al.
Publicado: (2023)

Striatal Vulnerability in Huntington’s Disease: Neuroprotection Versus Neurotoxicity
por: Morigaki, Ryoma, et al.
Publicado: (2017)

Metabolic and hormonal signatures in pre-manifest and manifest Huntington's disease patients
por: Wang, Rui, et al.
Publicado: (2014)

Dissociable Motivational Deficits in Pre-manifest Huntington’s Disease
por: Atkins, Kelly J., et al.
Publicado: (2020)

Sleep Quality and Related Clinical Manifestations in Huntington Disease
por: Maffi, Sabrina, et al.
Publicado: (2022)

Psychiatric manifestations of huntington’s disease: Two case reports
por: Göy, D., et al.
Publicado: (2021)

Neuroimaging of the Vulnerable Plaque
por: Lovblad, Karl-Olof, et al.
Publicado: (2015)

Vulnerability to Multidimensional Poverty: An Application to Colombian Households
por: Hernández, Jhon Edwar, et al.
Publicado: (2022)

Symptomatic treatment options for Huntington’s disease (guidelines of the German Neurological Society)
por: Saft, Carsten, et al.
Publicado: (2023)

Oromandibular Dyskinesia as the Initial Manifestation of Late-Onset Huntington Disease
por: Oh, Dong-Seok, et al.
Publicado: (2011)

Computerised Dynamic Posturography in Premanifest and Manifest individuals with Huntington’s Disease
por: Reyes, Alvaro, et al.
Publicado: (2018)

Visual Object Perception in Premanifest and Early Manifest Huntington’s Disease
por: Coppen, Emma M, et al.
Publicado: (2019)

Time will tell: Decision making in premanifest and manifest Huntington’s disease
por: Heim, Beatrice, et al.
Publicado: (2020)

Changes in brain activity with tominersen in early-manifest Huntington’s disease
por: Hawellek, D J, et al.
Publicado: (2022)

DISC1 and Huntington's Disease – Overlapping Pathways of Vulnerability to Neurological Disorder?
por: Boxall, Ruth, et al.
Publicado: (2011)

Transcriptional vulnerabilities of striatal neurons in human and rodent models of Huntington’s disease
por: Matsushima, Ayano, et al.
Publicado: (2023)

Analysis of the Circadian Regulation of Cancer Hallmarks by a Cross-Platform Study of Colorectal Cancer Time-Series Data Reveals an Association with Genes Involved in Huntington’s Disease
por: Yalçin, Müge, et al.
Publicado: (2020)

Neuroimaging in Menkes Disease
por: Ahmed, Molla I., et al.
Publicado: (2017)

Longitudinal Change in Gait and Motor Function in Pre-manifest Huntington’s Disease
por: Rao, Ashwini K., et al.
Publicado: (2011)

Altered brain mechanisms of emotion processing in pre-manifest Huntington's disease
por: Novak, Marianne J. U., et al.
Publicado: (2012)

Revealing the Timeline of Structural MRI Changes in Premanifest to Manifest Huntington Disease
por: Wijeratne, Peter A., et al.
Publicado: (2021)

Possible involvement of self-defense mechanisms in the preferential vulnerability of the striatum in Huntington's disease
por: Francelle, Laetitia, et al.
Publicado: (2014)

Impaired XK recycling for importing manganese underlies striatal vulnerability in Huntington's disease
por: Chhetri, Gaurav, et al.
Publicado: (2022)

Community perception of malaria in a vulnerable municipality in the Colombian Pacific
por: Rosero, Carol Yovanna, et al.
Publicado: (2020)

Divergent Effects of the Nonselective Adenosine Receptor Antagonist Caffeine in Pre-Manifest and Motor-Manifest Huntington’s Disease
por: Achenbach, Jannis, et al.
Publicado: (2022)

In vivo human molecular neuroimaging of dopaminergic vulnerability along the Alzheimer’s disease phases
por: Sala, Arianna, et al.
Publicado: (2021)

Tics as an initial manifestation of juvenile Huntington’s disease: case report and literature review
por: Cui, Shi-Shuang, et al.
Publicado: (2017)

Structural neuroimaging of social cognition in progressive non-fluent aphasia and behavioral variant of frontotemporal dementia
por: Couto, Blas, et al.
Publicado: (2013)

Evaluation of multi-modal, multi-site neuroimaging measures in Huntington's disease: Baseline results from the PADDINGTON study()
por: Hobbs, Nicola Z., et al.
Publicado: (2012)

Common and uncommon neuroimaging manifestations of ataxia: an illustrated guide for the trainee radiologist. Part 1 - acquired diseases
por: Jarry, Vinicius de Menezes, et al.
Publicado: (2022)

Clinical and mutational spectrum of Colombian patients with Pelizaeus Merzbacher Disease
por: Velasco Parra, Harvy Mauricio, et al.
Publicado: (2018)

Bupropion for the treatment of apathy in Huntington’s disease: A multicenter, randomised, double-blind, placebo-controlled, prospective crossover trial
por: Gelderblom, Harald, et al.
Publicado: (2017)

Classifying Parkinson’s Disease Patients With Syntactic and Socio-emotional Verbal Measures
por: Baez, Sandra, et al.
Publicado: (2020)

Insights Into Neuroimaging Findings of Patients With Coronavirus Disease 2019 Presenting With Neurological Manifestations
por: Chen, Boran, et al.
Publicado: (2020)

Clinical Management of Neuropsychiatric Symptoms of Huntington Disease: Expert-Based Consensus Guidelines on Agitation, Anxiety, Apathy, Psychosis and Sleep Disorders
por: Anderson, Karen E., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0s774g3f7euagelq19i7pl9doj